Review



insulinotropic polypeptide fxr farnesoid x receptor tgr5 takeda g protein coupled receptor 5 adipor adiponectin receptor rbp4 retinol  (Takeda)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Takeda insulinotropic polypeptide fxr farnesoid x receptor tgr5 takeda g protein coupled receptor 5 adipor adiponectin receptor rbp4 retinol
    Insulinotropic Polypeptide Fxr Farnesoid X Receptor Tgr5 Takeda G Protein Coupled Receptor 5 Adipor Adiponectin Receptor Rbp4 Retinol, supplied by Takeda, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/insulinotropic polypeptide fxr farnesoid x receptor tgr5 takeda g protein coupled receptor 5 adipor adiponectin receptor rbp4 retinol/product/Takeda
    Average 86 stars, based on 1 article reviews
    insulinotropic polypeptide fxr farnesoid x receptor tgr5 takeda g protein coupled receptor 5 adipor adiponectin receptor rbp4 retinol - by Bioz Stars, 2026-05
    86/100 stars

    Images



    Similar Products

    95
    MedChemExpress fxr agonist gw4064
    Fxr Agonist Gw4064, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fxr agonist gw4064/product/MedChemExpress
    Average 95 stars, based on 1 article reviews
    fxr agonist gw4064 - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    86
    Fujimori Kogyo fxr activation
    Fxr Activation, supplied by Fujimori Kogyo, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fxr activation/product/Fujimori Kogyo
    Average 86 stars, based on 1 article reviews
    fxr activation - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    86
    Takeda insulinotropic polypeptide fxr farnesoid x receptor tgr5 takeda g protein coupled receptor 5 adipor adiponectin receptor rbp4 retinol
    Insulinotropic Polypeptide Fxr Farnesoid X Receptor Tgr5 Takeda G Protein Coupled Receptor 5 Adipor Adiponectin Receptor Rbp4 Retinol, supplied by Takeda, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/insulinotropic polypeptide fxr farnesoid x receptor tgr5 takeda g protein coupled receptor 5 adipor adiponectin receptor rbp4 retinol/product/Takeda
    Average 86 stars, based on 1 article reviews
    insulinotropic polypeptide fxr farnesoid x receptor tgr5 takeda g protein coupled receptor 5 adipor adiponectin receptor rbp4 retinol - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    86
    Takeda farnesoid x receptor
    Farnesoid X Receptor, supplied by Takeda, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/farnesoid x receptor/product/Takeda
    Average 86 stars, based on 1 article reviews
    farnesoid x receptor - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    86
    Takeda farnesoid x receptor fxr
    Farnesoid X Receptor Fxr, supplied by Takeda, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/farnesoid x receptor fxr/product/Takeda
    Average 86 stars, based on 1 article reviews
    farnesoid x receptor fxr - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    fxr  (Takeda)
    86
    Takeda fxr
    Schematic illustration of the vicious cycle underlying bile duct injury in PBC. This figure illustrates that immune disturbance, metabolism disorder and BEC damage form a self-reinforcing loop in PBC. Central to all these processes is imbalanced T cell subsets, characterized by a high Th17/Treg ratio that can be exacerbated by γδ T cells. Dendritic cells (DCs) and macrophages (Mφ) secrete IL-23, driving STAT3-dependent Th17 differentiation/expansion. γδ T cells also exert an upstream effect through the secretion of IL-21 that promotes Th17 polarization while promoting the instability of Tregs. IL-17A from Th17s affects BECs, which induces release of pro-inflammatory cytokines and chemokines that recruit immune-cells. BEC injury occurs mainly via CTLs using perforin-granzyme pathway, leading to the apoptosis of BEC and loss of bile ducts. This immune damage is amplified by another metabolic feedback loop: defective BEC mitophagy results in accumulation and secretion of mitochondrial DAMPs (e.g., PDC-E2), inducing the activation of innate immunity and promoting a Th17 response; while granzymes released from CTLs aggravate the mitochondrial injury in BECs. As a counter-regulatory mechanism, bile acid-activated <t>FXR</t> and Peroxisome <t>proliferator-activated</t> <t>receptor</t> γ (PPARγ) signaling converge to suppress NF-κB-dependent inflammatory transcription, reducing inflammation and promoting restoration of T cell subset balance. Although not depicted as a separate node in the central schematic, tissue-resident memory T cells (Trm) are discussed in as an additional mechanism contributing to chronicity, relapse, and long-term immune persistence in PBC. Abbreviations: BEC, biliary epithelial cell; CTLs, cytotoxic T lymphocytes; DAMPs, damage-associated molecular patterns; FXR, farnesoid X receptor; PPARγ, peroxisome proliferator-activated receptor γ; TGR5, Takesda G protein-coupled receptor 5; SASP, Senescent-associated secretory phenotype; Trm, tissue-resident memory T cells.
    Fxr, supplied by Takeda, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fxr/product/Takeda
    Average 86 stars, based on 1 article reviews
    fxr - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc mouse anti fxr nr1h4 antibody
    Schematic illustration of the vicious cycle underlying bile duct injury in PBC. This figure illustrates that immune disturbance, metabolism disorder and BEC damage form a self-reinforcing loop in PBC. Central to all these processes is imbalanced T cell subsets, characterized by a high Th17/Treg ratio that can be exacerbated by γδ T cells. Dendritic cells (DCs) and macrophages (Mφ) secrete IL-23, driving STAT3-dependent Th17 differentiation/expansion. γδ T cells also exert an upstream effect through the secretion of IL-21 that promotes Th17 polarization while promoting the instability of Tregs. IL-17A from Th17s affects BECs, which induces release of pro-inflammatory cytokines and chemokines that recruit immune-cells. BEC injury occurs mainly via CTLs using perforin-granzyme pathway, leading to the apoptosis of BEC and loss of bile ducts. This immune damage is amplified by another metabolic feedback loop: defective BEC mitophagy results in accumulation and secretion of mitochondrial DAMPs (e.g., PDC-E2), inducing the activation of innate immunity and promoting a Th17 response; while granzymes released from CTLs aggravate the mitochondrial injury in BECs. As a counter-regulatory mechanism, bile acid-activated <t>FXR</t> and Peroxisome <t>proliferator-activated</t> <t>receptor</t> γ (PPARγ) signaling converge to suppress NF-κB-dependent inflammatory transcription, reducing inflammation and promoting restoration of T cell subset balance. Although not depicted as a separate node in the central schematic, tissue-resident memory T cells (Trm) are discussed in as an additional mechanism contributing to chronicity, relapse, and long-term immune persistence in PBC. Abbreviations: BEC, biliary epithelial cell; CTLs, cytotoxic T lymphocytes; DAMPs, damage-associated molecular patterns; FXR, farnesoid X receptor; PPARγ, peroxisome proliferator-activated receptor γ; TGR5, Takesda G protein-coupled receptor 5; SASP, Senescent-associated secretory phenotype; Trm, tissue-resident memory T cells.
    Mouse Anti Fxr Nr1h4 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti fxr nr1h4 antibody/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    mouse anti fxr nr1h4 antibody - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    86
    Takeda farnesoid x receptor takeda g protein coupled receptor 5
    Schematic illustration of the vicious cycle underlying bile duct injury in PBC. This figure illustrates that immune disturbance, metabolism disorder and BEC damage form a self-reinforcing loop in PBC. Central to all these processes is imbalanced T cell subsets, characterized by a high Th17/Treg ratio that can be exacerbated by γδ T cells. Dendritic cells (DCs) and macrophages (Mφ) secrete IL-23, driving STAT3-dependent Th17 differentiation/expansion. γδ T cells also exert an upstream effect through the secretion of IL-21 that promotes Th17 polarization while promoting the instability of Tregs. IL-17A from Th17s affects BECs, which induces release of pro-inflammatory cytokines and chemokines that recruit immune-cells. BEC injury occurs mainly via CTLs using perforin-granzyme pathway, leading to the apoptosis of BEC and loss of bile ducts. This immune damage is amplified by another metabolic feedback loop: defective BEC mitophagy results in accumulation and secretion of mitochondrial DAMPs (e.g., PDC-E2), inducing the activation of innate immunity and promoting a Th17 response; while granzymes released from CTLs aggravate the mitochondrial injury in BECs. As a counter-regulatory mechanism, bile acid-activated <t>FXR</t> and Peroxisome <t>proliferator-activated</t> <t>receptor</t> γ (PPARγ) signaling converge to suppress NF-κB-dependent inflammatory transcription, reducing inflammation and promoting restoration of T cell subset balance. Although not depicted as a separate node in the central schematic, tissue-resident memory T cells (Trm) are discussed in as an additional mechanism contributing to chronicity, relapse, and long-term immune persistence in PBC. Abbreviations: BEC, biliary epithelial cell; CTLs, cytotoxic T lymphocytes; DAMPs, damage-associated molecular patterns; FXR, farnesoid X receptor; PPARγ, peroxisome proliferator-activated receptor γ; TGR5, Takesda G protein-coupled receptor 5; SASP, Senescent-associated secretory phenotype; Trm, tissue-resident memory T cells.
    Farnesoid X Receptor Takeda G Protein Coupled Receptor 5, supplied by Takeda, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/farnesoid x receptor takeda g protein coupled receptor 5/product/Takeda
    Average 86 stars, based on 1 article reviews
    farnesoid x receptor takeda g protein coupled receptor 5 - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    Image Search Results


    Schematic illustration of the vicious cycle underlying bile duct injury in PBC. This figure illustrates that immune disturbance, metabolism disorder and BEC damage form a self-reinforcing loop in PBC. Central to all these processes is imbalanced T cell subsets, characterized by a high Th17/Treg ratio that can be exacerbated by γδ T cells. Dendritic cells (DCs) and macrophages (Mφ) secrete IL-23, driving STAT3-dependent Th17 differentiation/expansion. γδ T cells also exert an upstream effect through the secretion of IL-21 that promotes Th17 polarization while promoting the instability of Tregs. IL-17A from Th17s affects BECs, which induces release of pro-inflammatory cytokines and chemokines that recruit immune-cells. BEC injury occurs mainly via CTLs using perforin-granzyme pathway, leading to the apoptosis of BEC and loss of bile ducts. This immune damage is amplified by another metabolic feedback loop: defective BEC mitophagy results in accumulation and secretion of mitochondrial DAMPs (e.g., PDC-E2), inducing the activation of innate immunity and promoting a Th17 response; while granzymes released from CTLs aggravate the mitochondrial injury in BECs. As a counter-regulatory mechanism, bile acid-activated FXR and Peroxisome proliferator-activated receptor γ (PPARγ) signaling converge to suppress NF-κB-dependent inflammatory transcription, reducing inflammation and promoting restoration of T cell subset balance. Although not depicted as a separate node in the central schematic, tissue-resident memory T cells (Trm) are discussed in as an additional mechanism contributing to chronicity, relapse, and long-term immune persistence in PBC. Abbreviations: BEC, biliary epithelial cell; CTLs, cytotoxic T lymphocytes; DAMPs, damage-associated molecular patterns; FXR, farnesoid X receptor; PPARγ, peroxisome proliferator-activated receptor γ; TGR5, Takesda G protein-coupled receptor 5; SASP, Senescent-associated secretory phenotype; Trm, tissue-resident memory T cells.

    Journal: Frontiers in Pharmacology

    Article Title: Molecular mechanisms underlying T cell subset imbalance and precision therapeutic targets in primary biliary cholangitis

    doi: 10.3389/fphar.2026.1769883

    Figure Lengend Snippet: Schematic illustration of the vicious cycle underlying bile duct injury in PBC. This figure illustrates that immune disturbance, metabolism disorder and BEC damage form a self-reinforcing loop in PBC. Central to all these processes is imbalanced T cell subsets, characterized by a high Th17/Treg ratio that can be exacerbated by γδ T cells. Dendritic cells (DCs) and macrophages (Mφ) secrete IL-23, driving STAT3-dependent Th17 differentiation/expansion. γδ T cells also exert an upstream effect through the secretion of IL-21 that promotes Th17 polarization while promoting the instability of Tregs. IL-17A from Th17s affects BECs, which induces release of pro-inflammatory cytokines and chemokines that recruit immune-cells. BEC injury occurs mainly via CTLs using perforin-granzyme pathway, leading to the apoptosis of BEC and loss of bile ducts. This immune damage is amplified by another metabolic feedback loop: defective BEC mitophagy results in accumulation and secretion of mitochondrial DAMPs (e.g., PDC-E2), inducing the activation of innate immunity and promoting a Th17 response; while granzymes released from CTLs aggravate the mitochondrial injury in BECs. As a counter-regulatory mechanism, bile acid-activated FXR and Peroxisome proliferator-activated receptor γ (PPARγ) signaling converge to suppress NF-κB-dependent inflammatory transcription, reducing inflammation and promoting restoration of T cell subset balance. Although not depicted as a separate node in the central schematic, tissue-resident memory T cells (Trm) are discussed in as an additional mechanism contributing to chronicity, relapse, and long-term immune persistence in PBC. Abbreviations: BEC, biliary epithelial cell; CTLs, cytotoxic T lymphocytes; DAMPs, damage-associated molecular patterns; FXR, farnesoid X receptor; PPARγ, peroxisome proliferator-activated receptor γ; TGR5, Takesda G protein-coupled receptor 5; SASP, Senescent-associated secretory phenotype; Trm, tissue-resident memory T cells.

    Article Snippet: These bile acids directly impair mitochondrial integrity, downregulate anion exchanger 2 expression, and reshape CD4 + T cell fate via signaling mediated by the FXR, Takeda G protein-coupled receptor 5 (TGR5), and the sphingosine-1-phosphate receptor-signal transducer and activator of transcription 3 (S1PR-STAT3) axis.

    Techniques: Amplification, Activation Assay